Current Treatment of Depression
Abstract
The author reviews current treatments for depression, emphasizing the biological therapies as the source of numerous developments in recent years. He outlines findings related to drug selection, the newer antidepressants, nonstandard antidepressants such as monoamine oxidase inhibitors, combined and maintenance drug therapy, and usefulness of plasma levels, along with developments in electroconvulsive therapy and cognitive and interpersonal therapy. Although some of the findings are technically arcane, he says, many of them can be translated into more effective patient care with the resources currently available to most psychiatrists.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
